HAIFA, Israel, June 13, 2011 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) today announced that according to the TASE announcement, its ordinary shares will be added to the Mid-Cap-50 Index on the TASE, beginning on June 15, 2011. The Mid-Cap-50 Index includes the 50 shares with the highest market capitalization that are not included in the TA-100 index.
Following the inclusion in the Mid-Cap-50 the company's ordinary shares will be included in the following TASE equity indexes: Biomed Index, Mid-Cap-50 TA Index, TA BlueTech-50 Index, TA Composite Index, Shares Index and the Industry Index.
About Pluistem Therapeutics Inc.
For more information about Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) visit , the content of which is not part of this press release. Follow Pluristem on Twitter @Pluristem.
The Pluristem Therapeutics Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6882
CONTACT: Pluristem Therapeutics Inc. William Prather R.Ph., M.D., Sr. VP Corporate Development 1-303-883-4954 William.PratherMD@pluristem.com Daya Lettvin Director Investor & Media Relations +972-54-674-5580 firstname.lastname@example.org Media Contact: Matthew Krieger Ruder Finn - for Pluristem +972-54-467-6950 email@example.com